oleic acid has been researched along with docetaxel anhydrous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Gao, X; Guo, W; Ling, Y; Liu, W; Luo, Y; Pang, J; Wei, K; Wen, X | 1 |
| Guan, J; Guo, W; He, Z; Lin, B; Luo, C; Sun, B; Sun, J; Sun, M; Wang, Y; Zhang, D; Zhang, H; Zhang, S | 1 |
| Beguinot, F; Calì, G; Conza, D; Cosimato, V; Formisano, P; Insabato, L; Liotti, A; Luongo, G; Mirra, P; Secondo, A; Terracciano, D; Ulianich, L | 1 |
| Cui, W; He, Z; Li, Z; Luo, C; Sun, B; Sun, J; Sun, M; Ye, Q; Zhang, S; Zhao, H | 1 |
| Decuzzi, P; Di Mascolo, D; Felici, A; Goldoni, L; Lisa Palange, A; Schlich, M | 1 |
5 other study(ies) available for oleic acid and docetaxel anhydrous
| Article | Year |
|---|---|
Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 2; Cell Cycle; Cell Line, Tumor; Cell Survival; Cysteine Endopeptidases; Docetaxel; Drug Carriers; Drug Compounding; Durapatite; Enzyme Activation; Flow Cytometry; Humans; Male; Membrane Potential, Mitochondrial; Nanoparticles; Oleic Acid; Particle Size; Prostatic Neoplasms; RNA, Small Interfering; Taxoids | 2010 |
Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Disulfides; Docetaxel; Female; Humans; Mice, Inbred BALB C; Nanostructures; Oleic Acid; Prodrugs; Taxoids | 2017 |
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.
Topics: Aged; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Middle Aged; Oleic Acid; Phenotype; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction | 2018 |
Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
Topics: Administration, Oral; Animals; Coumarins; Docetaxel; Drug Carriers; Drug Liberation; Emulsions; Intestinal Mucosa; Intestines; Mice; Oleic Acid; Particle Size; Prodrugs; Rats; Rats, Sprague-Dawley; Solubility; Sulfides; Thiazoles | 2019 |
Boosting the therapeutic efficacy of discoidal nanoconstructs against glioblastoma with rationally designed PEG-Docetaxel conjugates.
Topics: Animals; Antineoplastic Agents; Docetaxel; Glioblastoma; Mice; Nanoparticles; Oleic Acid; Polyethylene Glycols; Taxoids | 2022 |